Poland· PL-100083342
Gemiderma
A boric acid products product containing acidum boricum, registered in Poland by Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI". The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Acidum boricum is registered in 2 of 19 countries.
Countries holding a registration under ATC D08AD (boric acid products), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Acidum boricum · ATC D08AD
2 / 19 countries
- Belgiumprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Acidum boricum
- Manufacturer
- Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI"
- Country
- Poland (PL)
- ATC code
- D08AD
- ATC class
- Boric acid products
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990256716
- gtin05909990256723
- gtin05909990256730
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acidum boricum in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBoric acid 2% ear dropsSpecial Order
- Japanホウ酸中北薬品
- United StatesHYLAFEMU.S. PHARMACEUTICAL CORPORATION
- BelgiumBoorzuurvaseline Sterop 10 %Laboratoires Sterop
- NorwayBorsyre SASykehusapoteket Oslo, Rikshospitalet
- FinlandCollyrium BoricumOrion Corporation Orion Pharma
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Hungary · Acidi Borici Fono Viii. Naturland
- Italy · Acido Borico Afom, Acido Borico Almus
- Latvia · Borskabes Rff
- Slovakia · Solutio Acidi Borici 3%, Solutio Jarisch
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b93e0969-aa5d-4a83-8e86-285934e176dd GET /v1/drugs/b93e0969-aa5d-4a83-8e86-285934e176dd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "5 mg/g",
"packaging": "05909990256716 ¦ OTC ¦ Skasowane ¦ 12545\n1 op. 20 g\n05909990256723 ¦ OTC ¦ 13167\n1 tuba 20 g\n05909990256730 ¦ OTC ¦ Skasowane ¦ 13168\n1 op. 30 g",
"substance": "Acidum boricum 500 mg",
"common_name": "Acidum boricum",
"pl_product_id": "100083342",
"pozwolenie_nr": "02567",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about acidum boricum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.